Granite Bay Wealth Management’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-5,715
Closed -$554K 222
2023
Q4
$554K Buy
5,715
+3,510
+159% +$339K 0.01% 249
2023
Q3
$224K Buy
+2,205
New +$224K ﹤0.01% 302

Other funds holding NVS

Granite Bay Wealth Management's NVS Position: Q1 2024 in Review

Granite Bay Wealth Management sold out of Novartis (NVS) in Q1 2024, closing a stake of 5,715 shares — an estimated $554K sold.

Granite Bay Wealth Management first reported a position in NVS in Q3 2023 and held it in 2 quarters. The position peaked at $554K in Q4 2023. 1,253 funds tracked by Wall St. Rank hold NVS as of Q1 2024.

  • Granite Bay Wealth Management reported no remaining Novartis position as of Q1 2024 after selling out during the quarter.
  • Granite Bay Wealth Management sold 5,715 Novartis shares in Q1 2024, an estimated $554K.
  • Granite Bay Wealth Management first reported a position in Novartis in Q3 2023 and held it in 2 quarters.
  • Granite Bay Wealth Management's Novartis position peaked at $554K in Q4 2023.
  • 1,253 funds tracked by Wall St. Rank held Novartis as of Q1 2024.

Based on Granite Bay Wealth Management's 13F filing for Q1 2024, filed 30 Apr 2024.